Joshua Meeks
@JoshMeeks
Followers
4K
Following
14K
Media
309
Statuses
2K
Urologic Oncologist and Scientist at Northwestern University K-index:3.7
Chicago
Joined July 2009
RT @NM_Urology: The @NorthwesternMed Urology Department is celebrating 125 years of excellence! As we celebrate this historic anniversary,….
0
9
0
RT @daviesbj: Priority review for TAR200 pretzel. A lot of uros are looking forward to giving this (as opposed to the other more hyped ones….
0
1
0
Blazing-fast image creation – using just your voice. Try Grok Imagine.
278
554
3K
RT @BladderCancerUS: => Please share! @PGrivasMDPhD @montypal @m_e_nielsen @SpiessPhilippe @FaltasLab @zklaassen_md @brian_rini @JoshMeeks….
0
3
0
Deeply honored and truly grateful to @JedUro1 and @AndrewMcD_MD at @UABMedicine, @UABUrology, and @UABradonc for the incredible opportunity to serve as a special visiting professor in Birmingham discussing bladder preservation. Thank you for your generosity and hospitality!
1
9
76
RT @Uromigos: @JoshMeeks provides an amazing overview of the significant data emerging in the BCG-unresponsive NMIBC space, focusing on the….
0
29
0
RT @BenjaminPradere: Great pleasure during #AUA25 to discuss with @JoshMeeks and @UroDocAsh the futur of BCG naive field.The tremendous @I….
urotoday.com
Ashish Kamat is joined by Benjamin Pradere and Joshua Meeks to debate whether BCG remains the "king" of bladder cancer treatment. Dr. Meeks argues BCG's dominance, citing its 60-80% response rates,...
0
2
0
Very cool data. I hear so many questions about what patients can change to reduce their risk of bladder cancer. Is this the direct impact of animal proteins or microbiome?.
bjui-journals.onlinelibrary.wiley.com
Objective Low carbohydrate diet (LCD), a summary score considering sources of all macronutrients in a dietary pattern, is defined by lower intakes of carbohydrates and higher intakes of proteins...
2
4
12
RT @DrChoueiri: 📢 #ASCO25 | NIAGARA ctDNA Analysis | MIBC pts on perioperative durvalumab: Baseline ctDNA+ in a subset linked to shorter EF….
0
20
0
RT @drenriquegrande: #Niagara study at #ASCO25: Pre-surgery ctDNA is prognostic in perioperative MIBC. Being ctDNA– ≠ pCR, but if ctDNA+ →….
0
10
0
RT @JussiNikkola: NIAGARA ctDNA results presented at #ASCO25 🧬. ctDNA is prognostic ➡️ ctDNA negative patients have good DFS and ctDNA posi….
0
7
0
RT @GUOncologyNow: 👉 Dr. @tompowles1 shared the results of the phase 3 NIAGARA trial here at @ASCO. Read more about the study and its findi….
0
3
0
RT @tompowles1: 1/2 ctDNA data for durvalumab+NAC in MIBC from NIAGARA #ASCO25. 57%,22%,9% of pts are ctDNA +ve at baseline/post NAC/post….
0
45
0
One of my favorite things about spring is our annual visiting professor. Now named after Anthony J Schaeffer. This year we hosted James Eastham from @MSKCancerCenter. @NM_Urology.
1
6
67
RT @Larvol: As May is Bladder Cancer Awareness Month, @Larvol CLIN highlights the top 10 trials from the @AmerUrological (AUA) 2025. Disc….
0
18
0
RT @_backtableUro: May is Bladder Cancer Awareness Month! 🧡 Throughout the month, we’ll be spotlighting recent episodes focused on this com….
0
4
0
0
2
13
RT @NU_BSA: Please join us in congratulating Ali Shilatifard, PhD (@ShilatifardLab), the Robert Francis Furchgott Professor and chair of Bi….
0
10
0